Detalles de la búsqueda
1.
Deconvolution of intergenic polymorphisms determining high expression of Factor H binding protein in meningococcus and their association with invasive disease.
PLoS Pathog
; 17(3): e1009461, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33770146
2.
Structure of a protective epitope reveals the importance of acetylation of Neisseria meningitidis serogroup A capsular polysaccharide.
Proc Natl Acad Sci U S A
; 117(47): 29795-29802, 2020 11 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-33158970
3.
Expression of factor H binding protein in meningococcal strains can vary at least 15-fold and is genetically determined.
Proc Natl Acad Sci U S A
; 113(10): 2714-9, 2016 Mar 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-26888286
4.
Effectiveness of Meningococcal B Vaccine against Endemic Hypervirulent Neisseria meningitidis W Strain, England.
Emerg Infect Dis
; 22(2): 309-11, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26811872
5.
Prediction by genetic MATS of 4CMenB vaccine strain coverage of invasive meningococcal serogroup B isolates circulating in Taiwan between 2003 and 2020.
mSphere
; : e0022024, 2024 May 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38752729
6.
Transcriptional regulation of the nadA gene in Neisseria meningitidis impacts the prediction of coverage of a multicomponent meningococcal serogroup B vaccine.
Infect Immun
; 81(2): 560-9, 2013 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-23230289
7.
Qualitative and quantitative assessment of meningococcal antigens to evaluate the potential strain coverage of protein-based vaccines.
Proc Natl Acad Sci U S A
; 107(45): 19490-5, 2010 Nov 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-20962280
8.
Neisseria meningitidis GNA2132, a heparin-binding protein that induces protective immunity in humans.
Proc Natl Acad Sci U S A
; 107(8): 3770-5, 2010 Feb 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-20133713
9.
OpcA and PorB are novel bactericidal antigens of the 4CMenB vaccine in mice and humans.
NPJ Vaccines
; 8(1): 54, 2023 Apr 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37045859
10.
Bactericidal killing of meningococcal W strains isolated in Argentina by the sera of adolescents and infants immunized with 4-component meningococcal serogroup B vaccine (4CMenB).
Hum Vaccin Immunother
; 19(3): 2288389, 2023 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38111094
11.
Synergistic activity of antibodies in the multicomponent 4CMenB vaccine.
Expert Rev Vaccines
; 21(5): 645-658, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35257644
12.
Bactericidal antibodies against hypervirulent Neisseria meningitidis C field strains following MenC-CRM or MenACWY-CRM priming and MenACWY-CRM booster in children.
Hum Vaccin Immunother
; 17(5): 1442-1449, 2021 05 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33325757
13.
Cross-reactivity of 4CMenB vaccine-induced antibodies against meningococci belonging to non-B serogroups in Italy.
Hum Vaccin Immunother
; 17(7): 2225-2231, 2021 07 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33522380
14.
Four-component Meningococcal Serogroup B Vaccine Induces Antibodies With Bactericidal Activity Against Diverse Outbreak Strains in Adolescents.
Pediatr Infect Dis J
; 40(2): e66-e71, 2021 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33060520
15.
4CMenB Immunization Induces Serum Bactericidal Antibodies Against Non-Serogroup B Meningococcal Strains in Adolescents.
Infect Dis Ther
; 10(1): 307-316, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-33185849
16.
Investigating the candidacy of LPS-based glycoconjugates to prevent invasive meningococcal disease: immunology of glycoconjugates with high carbohydrate loading.
Glycoconj J
; 27(7-9): 643-8, 2010 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-20922476
17.
Does vaccination with 4CMenB convey protection against meningococcal serogroup B strains not predicted to be covered by MATS? A study of the UK clonal complex cc269.
Hum Vaccin Immunother
; 16(4): 945-948, 2020 04 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31770063
18.
Multicomponent meningococcal serogroup B vaccination elicits cross-reactive immunity in infants against genetically diverse serogroup C, W and Y invasive disease isolates.
Vaccine
; 38(47): 7542-7550, 2020 11 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33036804
19.
Evaluation of strain coverage of the multicomponent meningococcal serogroup B vaccine (4CMenB) administered in infants according to different immunisation schedules.
Hum Vaccin Immunother
; 15(3): 725-731, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30352000
20.
Outbreaks of meningococcal B infection and the 4CMenB vaccine: historical and future perspectives.
Expert Rev Vaccines
; 14(5): 713-36, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25603916